RELATED CONTENT
May 28, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...
May 28, 2024 
April 11, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced today ...
April 11, 2024 
April 3, 2024 — Densitas, a global leader in artificial intelligence solutions for breast cancer screening, announces ...
April 03, 2024 
November 20, 2020 — Densitas Inc., a global provider of A.I. technologies for digital mammography and breast screening ...
November 20, 2020 
November 16, 2020 — Densitas Inc., a leading provider of A.I. technologies for digital mammography and breast screening ...
November 16, 2020 
Densitas Inc. announced that its U.S. Food and Drug Administration (FDA)-cleared densitas densityai breast density assessment software will be available on the Nuance AI Marketplace. The company said the marketplace provides access to more than 70 percent of all radiologists across the largest network of connected healthcare facilities in the U.S.
October 21, 2019 
Densitas Inc. announced it has won a procurement of its densitas densityai software for deployment in up to 24 breast cancer screening clinics across Germany. These clinics will provide breast density measurements at point of care to identify women for supplemental breast cancer screening as part of the DIMASOS 2 Trial.
September 20, 2019 
Breast imaging analytics company Densitas Inc. announced a new collaboration partnership with TeleMammography Specialists of Decatur, Ga. TeleMammography Specialists will be the first U.S. beta user for the new densitasquality solution from Densitas, which will be used to improve the communications and information sharing needed to meet EQUIP (Enhancing Quality Using the Inspection Program) guidelines. TeleMammography Specialists will also implement the recently released densitasdensity automated breast density assessment software.
February 14, 2019 
Breast imaging analytics company Densitas Inc. announced the signing of a new Alliance Partner Agreement with Blackford. This agreement gives Blackford the right to promote, market, sell, distribute and license densitasdensity directly via integration with the Blackford Platform. Work will now commence to integrate densitasdensity with the Blackford Platform. Densitas CEO Mohamed Abdolell said integrating with Blackford will shorten Densitas’ time to market and shorten the sales cycle.
December 19, 2018 
Densitas Inc. has received U.S. Food and Drug Administration (FDA) clearance for its DENSITAS|density automated breast density software. The software analyzes the same processed digital mammograms that radiologists view and are routinely stored in picture archiving and communication systems (PACS).
April 13, 2018